Abstract
We have assessed the efficacy and tolerability of vigabatrin (VGB) in 60 patients with drug-resistant focal epilepsy. VGB reduced seizures by ≥50% in 56% of the patients. VGB was most efficient in cryptogenic epilepsies, in younger patients, in patients with a single temporal focus and in the less severe epilepsies.
Translated title of the contribution | Treatment with Vigabatrin in focal epilepsies: Retrospective study of 60 cases |
---|---|
Original language | Italian |
Pages (from-to) | 89-90 |
Number of pages | 2 |
Journal | Bollettino - Lega Italiana contro l'Epilessia |
Issue number | 86-87 |
Publication status | Published - 1994 |
ASJC Scopus subject areas
- Clinical Neurology